Epigenomic mapping identifies a super-enhancer repertoire that regulates cell identity in bladder cancers through distinct transcription factor networks [siZBED2_siFOXA1]. Epigenomic mapping identifies a super-enhancer repertoire that regulates cell identity in bladder cancers through distinct transcription factor networks [siZBED2_siFOXA1]
收藏NIAID Data Ecosystem2026-03-13 收录
官方服务：
资源简介：
RNA-seq Series of bladder carcinoma cell lines RT112 and SCaBER treated by siZBED2 and FOXA1. Overall design: RT112 and SCaBER bladder cancer cell lines were treated with siRNA against ZBED2 and FOXA1.
创建时间：
2022-02-11
